 risk myelodysplasia leukaemia etoposid cisplatin bleomycin germ-cel tumour cytostat drug agent leukaemogen report case acut myeloid leukaemia myelodysplasia cohort patient germ-cel tumour etoposid cisplatin bleomycin mean cumul risk leukaem complic SE year start etoposide-contain chemotherapi risk gener popul rel risk overt leukaemia CI leukaemia previou cohort patient germ-cel tumour cisplatin bleomycin vinblastin increas risk leukaemia due combin cisplatin bleomycin work excess leukaemia patient germ-cel tumour cisplatin bleomycin vinblastin risk leukaemia patient leukaem complic cumul dose etoposid leukaemia patient leukaem patient chromosom transloc band transloc aberr characterist myelodysplasia acut leukaemia therapi cytostat agent dna-topoisomeras II